Because in some tumor specimens the proportion of malignant cells is relatively low and that of immune cells is particularly high, we considered strategies to deplete CD45+ immune cells as a way to both enrich for epithelial cells without specific markers and to maintain any stromal cells. Here, PTPRC is linked to neoplasm.